上调后的42澳元目标价表明，尽管即期增长前景可能有限，但Jefferies仍认为Ansell股票的估值略高于此前水平。转向持有评级反映了考虑到预期市场条件后，对该股近期升值潜力的更谨慎展望。根据 InvestingPro 数据，公司已连续22年保持派息，当前股息收益率为1.86%，分析表明基于公允价值计算，该股略显低估。订阅者可以访问额外11个ProTips和全面的财务指标进行深入分析。

Ansell is expanding its manufacturing to be less reliant on China Mayne Pharma pre-announces a strong first-half earnings recovery Alterity Therapeutics raises $40 million on the back of encouraging ...

SYDNEY—Trade tariffs could push Ansell to change where it makes some of its personal-protection equipment, but that doesn’t necessarily mean moving jobs to the U.S., its chief executive said.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

“Diversity and Equity in an Age of Denial: Actions Speak Louder Than Words” is the title of UB’s fifth annual Beyond the Knife lecture on Feb. 27. David Ansell, author of “The Death Gap: How ...

Thank you, and thank you to all of you for your continued interest in Ansell as we update you on our progress over the last 6 months. And let me begin with a slide that summarizes the content we ...

David Ansell, MD, author of “The Death Gap: How Inequality Kills,” is the keynote speaker. Ansell is Michael E. Kelly Presidential Professor of Internal Medicine and senior vice president/associate ...

Ansell’s focus is on its key brands across industrial and healthcare settings. Each market is quite fragmented and Ansell’s market share varies by subsegment, but the firm has consistently ...